Brief: Atossa Therapeutics Announces First Quarter 2023 Financial Results And Provides Corporate Update
15/05/2023 14:16
May 15 (Reuters) - Atossa Therapeutics Inc ATOS.O :
* ATOSSA THERAPEUTICS ANNOUNCES FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* ATOSSA THERAPEUTICS - ENDED Q1 2023 WITH $103.9 MILLION OF
CASH
AND CASH EQUIVALENTS AND NO DEBT
* ATOSSA THERAPEUTICS - QTRLY LOSS PER SHARE OF COMMON STOCK
$0.05
Source text for Eikon: ID:nGNX27gz4h
Further company coverage: ATOS.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary